AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15383382 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-second wait time
Number of subjects: 0
Study 11498597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9571555 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical aqueous indomethacin
Number of subjects: 120
Study 9571555 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ketorolac
Number of subjects: 120
Study 7918070 — intervention group
Group type: EXPERIMENTAL
Intervention: AML/TMDS
Number of subjects: 230
Study 7918070 — intervention group
Group type: COMPARATOR
Intervention: AML without TMDS
Number of subjects: 230
Study 7918070 — intervention group
Group type: COMPARATOR
Intervention: Absence of TMDS in AML
Number of subjects: 230
Study 2963192 — intervention group
Group type: EXPERIMENTAL
Intervention: Glipizide
Number of subjects: 53
Study 2963192 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 31296738 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbiota-directed complementary food (MDCF) prototypes
Number of subjects: 0
Study 31296738 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study 28363318 — intervention group
Group type: COMPARATOR
Intervention: Pamphlet (N=25)
Number of subjects: 76
Study 28363318 — intervention group
Group type: COMPARATOR
Intervention: Computer (N=24)
Number of subjects: 76
Study 28363318 — intervention group
Group type: COMPARATOR
Intervention: Computer+Mastery (N=27)
Number of subjects: 76
Study 28363318 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 76
Study 26588688 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 344
Study 26588688 — intervention group
Group type: COMPARATOR
Intervention: Traditional scalpel
Number of subjects: 344
Study 24057426 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine plus hydromorphone 100 μg
Number of subjects: 88
Study 24057426 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal bupivacaine alone
Number of subjects: 88
Study 22289547 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ml normal saline
Number of subjects: 295
Study 22289547 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ml normal saline containing adrenaline (5 μg/ml)
Number of subjects: 295
Study 22289547 — intervention group
Group type: COMPARATOR
Intervention: Direct epidural catheter placement
Number of subjects: 295
Study 19842005 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived discrimination (DAS scale) in US-born Latinos
Number of subjects: 1067
Study 19842005 — intervention group
Group type: EXPERIMENTAL
Intervention: Report of any doctor or medical staff discrimination in foreign-born Latinos
Number of subjects: 1067
Study 19842005 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor discrimination and higher DAS in US-born Latinos
Number of subjects: 1067
Study 19842005 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrimination on doctor-patient communication in foreign-born Latinos
Number of subjects: 1067
Study 16672731 — intervention group
Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory‐II (BDI‐II)
Number of subjects: 598
Study 16672731 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-factor solution (somatic, affective, and cognitive)
Number of subjects: 598
Study 16672731 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatic symptoms
Number of subjects: 598
Study 15636218 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with senile cataract
Number of subjects: 3
Study 15636218 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with diabetic cataract
Number of subjects: 3
Study 15636218 — intervention group
Group type: COMPARATOR
Intervention: Healthy adults (without cataract and without diabetes mellitus)
Number of subjects: 3
Study 11404645 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisite randomized controlled trials (RCTs)
Number of subjects: 0
Study 11404645 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 9728121 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilization appliance
Number of subjects: 58
Study 9728121 — intervention group
Group type: COMPARATOR
Intervention: Control appliance
Number of subjects: 58
Study 7956269 — intervention group
Group type: EXPERIMENTAL
Intervention: Good description (G) of assignment methods
Number of subjects: 200
Study 7956269 — intervention group
Group type: EXPERIMENTAL
Intervention: Fair description (F) of assignment methods
Number of subjects: 200
Study 7956269 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor description (P) of assignment methods
Number of subjects: 200
Study 7956269 — intervention group
Group type: EXPERIMENTAL
Intervention: No description (N) of assignment methods
Number of subjects: 200
Study 2738227 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic programme of nursing support in addition to routine care
Number of subjects: 60
Study 2738227 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 60
Study 31439336 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg dual therapy
Number of subjects: 2725
Study 31439336 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg dual therapy
Number of subjects: 2725
Study 31439336 — intervention group
Group type: COMPARATOR
Intervention: Warfarin triple therapy
Number of subjects: 2725
Study 26446728 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon Angioplasty (DCBA)
Number of subjects: 119
Study 26446728 — intervention group
Group type: COMPARATOR
Intervention: Standard Balloon Angioplasty (POBA)
Number of subjects: 119
Study 26446728 — intervention group
Group type: EXPERIMENTAL
Intervention: DCBA
Number of subjects: 119
Study 26446728 — intervention group
Group type: COMPARATOR
Intervention: POBA
Number of subjects: 119
Study 22549238 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% taprenepag isopropyl monotherapy
Number of subjects: 32
Study 22549238 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% taprenepag isopropyl in combination with 0.005% latanoprost
Number of subjects: 32
Study 22549238 — intervention group
Group type: COMPARATOR
Intervention: 0.1% taprenepag isopropyl monotherapy and combination therapy
Number of subjects: 32
Study 21653650 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-PACK programme (12 wards)
Number of subjects: 16000
Study 21653650 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group (12 wards)
Number of subjects: 16000
Study 19114073 — intervention group
Group type: EXPERIMENTAL
Intervention: L. casei rhamnosus
Number of subjects: 1062
Study 19114073 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-species probiotic
Number of subjects: 1062
Study 19114073 — intervention group
Group type: EXPERIMENTAL
Intervention: L. rhamnosus T cell-1
Number of subjects: 1062
Study 17020889 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (sirolimus or paclitaxel-eluting)
Number of subjects: 8221
Study 17020889 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stents
Number of subjects: 8221
Study 17020889 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 8221
Study 17020889 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents
Number of subjects: 8221
Study 15369608 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma levels of six carotenoids (alpha-carotene, beta-carotene, beta-cryptoxanthin, lycopene, lutein, zeaxanthin)
Number of subjects: 3043
Study 12771983 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents who lost a child with incident cancer
Number of subjects: 1630
Study 12771983 — intervention group
Group type: COMPARATOR
Intervention: Unexposed parents with incident cancer
Number of subjects: 1630
Study 11094663 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenoxicam 20 mg
Number of subjects: 30
Study 11094663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 8815853 — intervention group
Group type: EXPERIMENTAL
Intervention: PROPATH Program
Number of subjects: 46
Study 8815853 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care only
Number of subjects: 46
Study 1563059 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone, 0.75 mg.kg‐1, administered ten minutes before separation from cardiopulmonary bypass (CPB)
Number of subjects: 100
Study 1563059 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 100
Study 3890520 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 43
Study 3890520 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study 3068365 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs (exact drugs not specified)
Number of subjects: 0
Study 3068365 — intervention group
Group type: COMPARATOR
Intervention: WOMAC instrument
Number of subjects: 0
Study 31837291 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention involving training for family physicians on contraceptive effectiveness counselling and access to rapid referral to long-acting reversible contraceptive insertion clinics.
Number of subjects: 740
Study 31837291 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual contraception counselling without intervention).
Number of subjects: 740
Study 31286871 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Patient Education (TPE) program
Number of subjects: 260
Study 31286871 — intervention group
Group type: COMPARATOR
Intervention: Conventional management of pain (before medical staff training to TPE)
Number of subjects: 260
Study 31286871 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational approach by health providers trained to TPE
Number of subjects: 260
Study 28455321 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting
Number of subjects: 183
Study 25771759 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm tourniquet IVRA with 10 mL of 0.5% lidocaine and 30 mL of 0.25% lidocaine
Number of subjects: 32
Study 25771759 — intervention group
Group type: COMPARATOR
Intervention: Conventional upper arm tourniquet IVRA with 40 mL of 0.5% lidocaine
Number of subjects: 32
Study 25771759 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm tourniquet IVRA
Number of subjects: 32
Study 24210183 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative chemotherapy followed by delayed nephrectomy
Number of subjects: 525
Study 24210183 — intervention group
Group type: COMPARATOR
Intervention: Immediate nephrectomy
Number of subjects: 525
Study 21739695 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at left Hegu (LI 4)
Number of subjects: 18
Study 21739695 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at left Dicang (ST 4)
Number of subjects: 18
Study 21739695 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture at left Houxi (SI 3)
Number of subjects: 18
Study 19838842 — intervention group
Group type: EXPERIMENTAL
Intervention: IMPACT intervention (n = 112)
Number of subjects: 215
Study 19838842 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 103)
Number of subjects: 215
Study 17130571 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D3
Number of subjects: 0
Study 17130571 — intervention group
Group type: COMPARATOR
Intervention: 400 IU vitamin D3
Number of subjects: 0
Study 15514280 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 daily servings of soy foods equivalent to 50 mg of isoflavones
Number of subjects: 220
Study 15514280 — intervention group
Group type: COMPARATOR
Intervention: Regular diet (Control)
Number of subjects: 220
Study 15514280 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime soy intake (questionnaire)
Number of subjects: 220
Study 15514280 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower soy intake during early life and higher soy intake during adulthood
Number of subjects: 220
Study 11324215 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediately loaded single-tooth implants in fresh extraction sites
Number of subjects: 26
Study 11324215 — intervention group
Group type: COMPARATOR
Intervention: Immediately loaded single-tooth implants in healed sites
Number of subjects: 26
Study 9560497 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-gloving
Number of subjects: 0
Study 9560497 — intervention group
Group type: COMPARATOR
Intervention: Single-gloving
Number of subjects: 0
Study 7930130 — intervention group
Group type: EXPERIMENTAL
Intervention: Study wards
Number of subjects: 192
Study 7930130 — intervention group
Group type: COMPARATOR
Intervention: Control wards
Number of subjects: 192
Study 3124597 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative total parenteral nutrition (TPN)
Number of subjects: 0
Study 30268694 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP (≥ 4 hours per night)
Number of subjects: 2483
Study 30268694 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 2483
Study 30268694 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone (Control)
Number of subjects: 2483
Study 28600913 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily SMBG with enhanced patient feedback (automatic tailored messages)
Number of subjects: 450
Study 28600913 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily SMBG
Number of subjects: 450
Study 28600913 — intervention group
Group type: COMPARATOR
Intervention: No SMBG
Number of subjects: 450
Study 28600913 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including no SMBG, once-daily SMBG, and once-daily SMBG with messaging)
Number of subjects: 450
Study 27107279 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (ten-session group intervention incorporating the Tree of Life narrative approach and constructivist psychoeducation)
Number of subjects: 80
Study 27107279 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial intervention
Number of subjects: 80
Study 23589107 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination with HLA-A*0201-modified tumor peptides and low-dose cyclophosphamide (CTX) and low-dose interleukin-2 (IL-2)
Number of subjects: 0
Study 23589107 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose IL-2
Number of subjects: 0
Study 23589107 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CTX
Number of subjects: 0
Study 23589107 — intervention group
Group type: COMPARATOR
Intervention: Vaccination with HLA-A*0201-modified tumor peptides
Number of subjects: 0
Study 20380779 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 80
Study 20380779 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-Term Psychodynamic Psychotherapy (STPP)
Number of subjects: 80
Study 20380779 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 80
Study 19395240 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation therapy targeting mental state attribution
Number of subjects: 24
Study 19395240 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation therapy targeting mental flexibility
Number of subjects: 24
Study 19395240 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 24
Study 16469146 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented milk with L. johnsonii La1
Number of subjects: 22
Study 16469146 — intervention group
Group type: COMPARATOR
Intervention: Placebo (fermented milk without L. johnsonii La1)
Number of subjects: 22
Study 15271201 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrument-independent no-scalpel vasectomy (IINSV)
Number of subjects: 449
Study 15271201 — intervention group
Group type: COMPARATOR
Intervention: Instrument-dependent no-scalpel vasectomy (IDNSV)
Number of subjects: 449
Study 11778923 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-induced extracorporeal low-density lipoprotein (LDL) precipitation (HELP) apheresis
Number of subjects: 53
Study 11778923 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with prednisolone and dextranes for 10 days
Number of subjects: 53
Study 9140210 — intervention group
Group type: EXPERIMENTAL
Intervention: Vanadyl sulphate treatment group
Number of subjects: 0
Study 9140210 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 7967704 — intervention group
Group type: EXPERIMENTAL
Intervention: Trace element content in hair of aplastic anemia patients
Number of subjects: 20
Study 7967704 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects (control)
Number of subjects: 20
Study 3425385 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual dietary instructions by a nurse
Number of subjects: 80
Study 3425385 — intervention group
Group type: COMPARATOR
Intervention: Short, written leaflet given by a doctor
Number of subjects: 80
Study 30247585 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper medial intergluteal sulcus infiltration at -30°, -10°, and 0° angles
Number of subjects: 10
Study 30247585 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle lower gluteal sulcus infiltration at -30°, 0°, and +15° angles
Number of subjects: 10
Study 30247585 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritrochanteric access at 0° and +10° and middle of the buttock at -30° angle
Number of subjects: 10
Study 30247585 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper medial intergluteal sulcus infiltration without -30° angle
Number of subjects: 10
Study 27230268 — intervention group
Group type: EXPERIMENTAL
Intervention: Arsenic educational interventions combined with fee-based water arsenic testing programs
Number of subjects: 285
Study 27230268 — intervention group
Group type: COMPARATOR
Intervention: Fee-based arsenic testing alone
Number of subjects: 285
Study 27230268 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased instrumental attitude
Number of subjects: 285
Study 27230268 — intervention group
Group type: EXPERIMENTAL
Intervention: Descriptive norm
Number of subjects: 285
Study 27230268 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping planning
Number of subjects: 285
Study 27230268 — intervention group
Group type: EXPERIMENTAL
Intervention: Commitment
Number of subjects: 285
Study 27230268 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance from the nearest arsenic-safe drinking water source
Number of subjects: 285
Study 25854021 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) combined with ultraviolet therapy
Number of subjects: 34
Study 25854021 — intervention group
Group type: COMPARATOR
Intervention: Medicine group (intravenous acyclovir, muscular cobamamide, topical acyclovir, TDP radiation)
Number of subjects: 34
Study 24044595 — intervention group
Group type: EXPERIMENTAL
Intervention: Combining behavioral, physical, and psychological criteria for recovery
Number of subjects: 96
Study 24044595 — intervention group
Group type: EXPERIMENTAL
Intervention: Defining recovery with abstinence from binge eating and purging
Number of subjects: 96
Study 22073385 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 16
Study 22073385 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 19479079 — intervention group
Group type: EXPERIMENTAL
Intervention: zidovudine/lamivudine+lopinavir/ritonavir
Number of subjects: 50
Study 19479079 — intervention group
Group type: COMPARATOR
Intervention: nevirapine+lopinavir/ritonavir
Number of subjects: 50
Study 17429101 — intervention group
Group type: COMPARATOR
Intervention: No Gap (immediate treatment)
Number of subjects: 2215
Study 17429101 — intervention group
Group type: EXPERIMENTAL
Intervention: Gap (16-week delay)
Number of subjects: 2215
Study 15552889 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease inhibitors, H2 receptor antagonists, and somatostatin analogues
Number of subjects: 0
Study 11380290 — intervention group
Group type: EXPERIMENTAL
Intervention: Chorionic villus sampling
Number of subjects: 51
Study 11380290 — intervention group
Group type: EXPERIMENTAL
Intervention: Early amniocentesis
Number of subjects: 51
Study 11380290 — intervention group
Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 51
Study 9171743 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy trials
Number of subjects: 40
Study 9171743 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic hernia repair trials
Number of subjects: 40
Study 9171743 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendicectomy trials
Number of subjects: 40
Study 9171743 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall trials reviewed
Number of subjects: 40
Study 9171743 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life assessment
Number of subjects: 40
Study 9171743 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic aspects study
Number of subjects: 40
Study 9171743 — intervention group
Group type: EXPERIMENTAL
Intervention: Sample size calculation
Number of subjects: 40
Study 9171743 — intervention group
Group type: EXPERIMENTAL
Intervention: Endpoints assessment
Number of subjects: 40
Study 8483655 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 - 'Big Band' music from the 1920s and 1930s during daily recreation period
Number of subjects: 60
Study 8483655 — intervention group
Group type: COMPARATOR
Intervention: Group 2 - Puzzle exercises during activity sessions
Number of subjects: 60
Study 8483655 — intervention group
Group type: COMPARATOR
Intervention: Group 3 - Standard recreational activities of drawing and painting
Number of subjects: 60
Study 3301220 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfur 2 percent plus salicylic acid 2 percent in a shampoo vehicle
Number of subjects: 48
Study 3301220 — intervention group
Group type: COMPARATOR
Intervention: Sulfur 2 percent in a shampoo vehicle
Number of subjects: 48
Study 3301220 — intervention group
Group type: COMPARATOR
Intervention: Salicylic acid 2 percent in a shampoo vehicle
Number of subjects: 48
Study 3301220 — intervention group
Group type: COMPARATOR
Intervention: Shampoo vehicle alone
Number of subjects: 48
Study 30009974 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial subluxation ratio
Number of subjects: 100
Study 30009974 — intervention group
Group type: EXPERIMENTAL
Intervention: Grip strength scores
Number of subjects: 100
Study 26563167 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalamine granules (MG) 1.5 g once daily
Number of subjects: 158
Study 26563167 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158